Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |